Competing interactions in artificial spin chains

The low-energy magnetic configurations of artificial frustrated spin chains are investigated using magnetic force microscopy and micromagnetic simulations. Contrary to most studies on two-dimensional artificial spin systems where frustration arises from the lattice geometry, here magnetic frustration originates from competing interactions between neighboring spins. By tuning continuously the strength and sign of these interactions, we show that different magnetic phases can be stabilized. Comparison between our experimental findings and predictions from the one-dimensional Anisotropic Next-Nearest-Neighbor Ising (ANNNI) model reveals that artificial frustrated spin chains have a richer phase diagram than initially expected. Besides the observation of several magnetic orders and the potential extension of this work to highly-degenerated artificial spin chains, our results suggest that the micromagnetic nature of the individual magnetic elements allows observation of metastable spin configurations.Comment: 5 pages, 4 figure

A Clinical and Epidemiological Investigation of the First Reported Human Infection With the Zoonotic Parasite Trypanosoma evansi in Southeast Asia

Background. Trypanosoma is a genus of unicellular parasitic flagellate protozoa. Trypanosoma brucei species and Trypanosoma cruzi are the major agents of human trypanosomiasis; other Trypanosoma species can cause human disease, but are rare. In March 2015, a 38-year-old woman presented to a healthcare facility in southern Vietnam with fever, headache, and arthralgia. Microscopic examination of blood revealed infection with Trypanosoma. Methods. Microscopic observation, polymerase chain reaction (PCR) amplification of blood samples, and serological testing were performed to identify the infecting species. The patient's blood was screened for the trypanocidal protein apolipoprotein L1 (APOL1), and a field investigation was performed to identify the zoonotic source. Results. PCR amplification and serological testing identified the infecting species as Trypanosoma evansi. Despite relapsing 6 weeks after completing amphotericin B therapy, the patient made a complete recovery after 5 weeks of suramin. The patient was found to have 2 wild-type APOL1 alleles and a normal serum APOL1 concentration. After responsive animal sampling in the presumed location of exposure, cattle and/or buffalo were determined to be the most likely source of the infection, with 14 of 30 (47%) animal blood samples testing PCR positive for T. evansi. Conclusions. We report the first laboratory-confirmed case of T. evansi in a previously healthy individual without APOL1 deficiency, potentially contracted via a wound while butchering raw beef, and successfully treated with suramin. A linked epidemiological investigation revealed widespread and previously unidentified burden of T. evansi in local cattle, highlighting the need for surveillance of this infection in animals and the possibility of further human cases

The scaling limit of the incipient infinite cluster in high-dimensional percolation. II. Integrated super-Brownian excursion

For independent nearest-neighbour bond percolation on Z^d with d >> 6, we prove that the incipient infinite cluster's two-point function and three-point function converge to those of integrated super-Brownian excursion (ISE) in the scaling limit. The proof is based on an extension of the new expansion for percolation derived in a previous paper, and involves treating the magnetic field as a complex variable. A special case of our result for the two-point function implies that the probability that the cluster of the origin consists of n sites, at the critical point, is given by a multiple of n^{-3/2}, plus an error term of order n^{-3/2-\epsilon} with \epsilon >0. This is a strong statement that the critical exponent delta is given by delta =2.Comment: 56 pages, 3 Postscript figures, in AMS-LaTeX, with graphicx, epic, and xr package

On the difference between type E and A OH/IR stars

The observed SEDs of a sample of 60 OH/IR stars are fitted using a radiative transfer model of a dusty envelope. Among the whole sample, 21 stars have reliable phase-lag distances while the others have less accurate distances. L*-P,Mlr-P and Mlr-L* relations have been plotted for these stars. It is found that type E (with emission feature at 10um and type A (with absorption feature at 10um) OH/IR stars have different L*-P and Mlr-L* relations while both of them follow a single Mlr-P relation. The type E stars are proven to be located in the area without large scale dense interstellar medium while the type A stars are located probably in dense interstellar medium. It is argued here that this may indicate the two types of OH/IR stars have different chemical composition or zero age main sequence mass and so evolve in different ways. This conclusion has reinforced the argument by Chen et al.(2001) who reached a similar conclusion from the galactic distribution of about 1000 OH/IR stars with the IRAS low-resolution spectra (LRS).Comment: 6 pages, 9 figures, 2 table

Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0

Abstract Background The Aptima HCV Quant Dx assay (Aptima assay) is a fully automated quantitative assay on the Panther® system. This assay is intended for confirmation of diagnosis and monitoring of HCV RNA in plasma and serum specimens. The purpose of the testing described in this paper was to evaluate the performance of the Aptima assay. Methods The analytical sensitivity, analytical specificity, precision, and linearity of the Aptima assay were assessed. The performance of the Aptima assay was compared to two commercially available HCV assays; the Abbott RealTime HCV assay (Abbott assay, Abbott Labs Illinois, USA) and the Roche COBAS Ampliprep/COBAS Taqman HCV Quantitative Test v2.0 (Roche Assay, Roche Molecular Systems, Pleasanton CA, USA). The 95% Lower Limit of Detection (LoD) of the assay was determined from dilutions of the 2nd HCV WHO International Standard (NIBSC 96/798 genotype 1) and HCV positive clinical specimens in HCV negative human plasma and serum. Probit analysis was performed to generate the 95% predicted detection limits. The Lower Limit of Quantitation (LLoQ) was established for each genotype by diluting clinical specimens and the 2nd HCV WHO International Standard (NIBSC 96/798 genotype 1) in HCV negative human plasma and serum. Specificity was determined using 200 fresh and 536 frozen HCV RNA negative clinical specimens including 370 plasma specimens and 366 serum specimens. Linearity for genotypes 1 to 6 was established by diluting armored RNA or HCV positive clinical specimens in HCV negative serum or plasma from 8.08 log IU/mL to below 1 log IU/mL. Precision was tested using a 10 member panel made by diluting HCV positive clinical specimens or spiking armored RNA into HCV negative plasma and serum. A method comparison was conducted against the Abbott assay using 1058 clinical specimens and against the Roche assay using 608 clinical specimens from HCV infected patients. In addition, agreement between the Roche assay and the Aptima assay using specimens with low HCV concentrations (</= 25 IU/mL by Roche) was tested using 107 clinical specimens. Results The 95% LoD was 5.1 IU/mL or lower for serum and 4.8 IU/mL or lower for plasma depending on the HCV genotype. The LLoQ for the assay was 10 IU/mL. Specificity was 100% with 95% confidence intervals of 99.6 to 100% for serum and plasma data combined. The assay demonstrated good linearity across the range for all genotypes. The Precision as estimated by the standard deviation (sd) was 0.17 log or lower across the range of the assay for both serum and plasma. HCV viral load results were compared using the Aptima assay and the Abbott assay giving a slope of 1.06, an intercept of 0.08 and an R2 of 0.98. HCV viral load results were compared for the Aptima and Roche assays giving a slope of 1.05, an intercept of −0.12 and an R2 of 0.96. Positive and negative agreement for the Aptima assay vs the Roche assay was 89% for low level specimens. Conclusion The Aptima assay is a highly sensitive and specific assay. The assay gave comparable HCV viral load results when compared to the Abbott and Roche assays. The performance of the Aptima assay makes it an excellent candidate for the detection and monitoring of HCV

Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3

Background: Current vector-based malaria control strategies are threatened by the rise of biochemical and behavioural resistance in mosquitoes. Researching mosquito traits of immunity and fertility is required to find potential targets for new vector control strategies. The seminal transglutaminase AgTG3 coagulates male Anopheles gambiae seminal fluids, forming a ‘mating plug’ that is required for male reproductive success. Inhibitors of AgTG3 can be useful both as chemical probes of A. gambiae reproductive biology and may further the development of new chemosterilants for mosquito population control. Methods: A targeted library of 3-bromo-4,5-dihydroxoisoxazole inhibitors were synthesized and screened for inhibition of AgTG3 in a fluorescent, plate-based assay. Positive hits were tested for in vitro activity using cross-linking and mass spectrometry, and in vivo efficacy in laboratory mating assays. Results: A targeted chemical library was screened for inhibition of AgTG3 in a fluorescent plate-based assay using its native substrate, plugin. Several inhibitors were identified with IC50 < 10 μM. Preliminary structure-activity relationships within the library support the stereo-specificity and preference for aromatic substituents in the chemical scaffold. Both inhibition of plugin cross-linking and covalent modification of the active site cysteine of AgTG3 were verified. Administration of an AgTG3 inhibitor to A. gambiae males by intrathoracic injection led to a 15% reduction in mating plug transfer in laboratory mating assays. Conclusions: A targeted screen has identified chemical inhibitors of A. gambiae transglutaminase 3 (AgTG3). The most potent inhibitors are known inhibitors of human transglutaminase 2, suggesting a common binding pose may exist within the active site of both enzymes. Future efforts to develop additional inhibitors will provide chemical tools to address important biological questions regarding the role of the A. gambiae mating plug. A second use for transglutaminase inhibitors exists for the study of haemolymph coagulation and immune responses to wound healing in insects

Facile fabrication and characterizations of nanostructured Fe2O3-TiO2 composite from Ilmenite ore

Fe2O3-TiO2 nanoparticles promises as a highly effective material for adsorption of heavy metals and used as photocatalyst for the removal of organic dye pollutants. In this study, nanostructured Fe2O3-TiO2 composite was successfully fabricated by one-step reaction of ilmenite ore at the high temperature in ambient condition. The resultant Fe2O3-TiO2 composite was characterized by using X-ray diffraction (XRD), Fourier Transform Infrared spectroscopy (FTIR), Scanning electron microscopy (SEM), nitrogen adsorption-desorption isotherm. The effects of sintered temperature and time on the formation of the Fe2O3-TiO2 nanocomposite were investigated in detail. The Fe2O3-TiO2 was formed from ilmenite ore after calcination at the temperature of 700oC in 3 hours, followed by a ball-milled process in 4 hours. The obtained Fe2O3-TiO2 composite has an average diameter of from 50 - 100 nm with the BET surface area of 7 m2/g